FDA Clears iRhythm’s Afib-Detecting Wearable Running Software Co-Developed By Verily

The ZEUS (Zio ECG Utilization Software) system for iRhythm’s Zio Watch detects and characterizes atrial fibrillation over time to aid doctors in diagnosing the condition. The company expects to begin commercializing it next year.

Zio Watch
Zio Watch • Source: iRhythm Technologies Inc

More from Digital Technologies

More from Medtech Insight